Navigation Links
Hospitalizations because of chicken pox down dramatically since implementation of vaccine

Since the introduction of the varicella (chicken pox) vaccine in 1995, hospitalizations and doctor visits because of chicken pox have dropped dramatically, according to a study in the August 17 issue of JAMA.

Varicella vaccine is recommended for routine immunization of children aged 12 to 18 months and for older susceptible children and adults in the United States, according to background information in the article. Before its licensure in 1995, almost everyone developed chicken pox; thus, incidence approximated the birth cohort, with about 13,000 hospitalizations and 100 to 150 deaths annually. Varicella vaccine coverage has increased steadily, reaching 81 percent in 2002 among children aged 19 to 35 months nationally, while varicella disease incidence has declined in all age groups. However, data documenting the impact of vaccination on varicella-related health care utilization have previously been limited.

Fangjun Zhou, Ph.D., M.S., of the National Immunization Program, Centers for Disease Control and Prevention, Atlanta, and colleagues conducted a study to determine the patterns of hospitalization and ambulatory visits for chicken pox and their associated medical expenditures in the United States, evaluating these factors beginning in 1994 (before availability of varicella vaccine) through 2002 (7 years after vaccine licensure). Data included enrollees (children and adults) of more than 100 health insurance plans of approximately 40 large U.S. employers.

The researchers found that from the prevaccination period to 2002, hospitalizations due to chicken pox declined by 88 percent (from 2.3 to 0.3 per 100,000 population) and ambulatory visits declined by 59 percent (from 215 to 89 per 100,000 population). Hospitalizations and ambulatory visits declined in all age groups, with the greatest declines among infants younger than 1 year. Total estimated direct medical expenditures for chicken pox hospitalizations and ambulatory visits declined by 7
'"/>

Source:JAMA and Archives Journals


Page: 1 2 3

Related biology news :

1. Six million Africans face famine because of locusts, drought
2. More species in the tropics because species have been there longer
3. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
4. What comes first…the chicken, the egg, or the bad attitude?
5. Geoscientists follow arsenic from chicken feed to streambeds
6. UF scientists restore sight to chickens with blinding disease
7. Origen publishes in Nature a robust and versatile method for creating transgenic chickens
8. Arsenic in chicken feed may pose health risks to humans, C&EN reports
9. New miniaturised chip dramatically reduces time taken for DNA analysis
10. Caloric restriction wont dramatically extend life span in humans: UCLA research
11. Simple idea to dramatically improve dengue vaccinations
Post Your Comments:
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the ... APAC Region 2015-2019"  report to their offering. ... market is advances in technology. With continuous advances ... solutions to the latest standard that meets the ...
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need ... your password, site key or the answer to your secret ... teacher? Today, Hoyos Labs , a ... will finally put an end to the frustration that comes ... . 1U leverages a user,s smartphone to acquire his or ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... Reportlinker.com announces that a new market research report is ... technologies,markets and companies http://www.reportlinker.com/p0203536/Biomarkers---technologiesmarkets-and-companies.html ... follows the broad definition of a biomarker as a ... an indicator of normal biological or pathogenic processes as ...
... methods may increase farm biodiversity, a combination of conventional ... way to maintain food production and protect wildlife. ... in UK landscapes by scientists at the Universities of ... more butterflies than conventional farms, but that a conventional ...
... College of Neuropsychopharmacology (ECNP) is pleased to announce ... ECNP Neuropsychopharmacology Award in recognition of his original ... ECNP Neuropsychopharmacology Award is presented annually and recognises ... The award is accompanied by a prize of ...
Cached Biology News:Reportlinker Adds Biomarkers - technologies, markets and companies 2Reportlinker Adds Biomarkers - technologies, markets and companies 3Reportlinker Adds Biomarkers - technologies, markets and companies 4Reportlinker Adds Biomarkers - technologies, markets and companies 5Reportlinker Adds Biomarkers - technologies, markets and companies 6Reportlinker Adds Biomarkers - technologies, markets and companies 7Reportlinker Adds Biomarkers - technologies, markets and companies 8Reportlinker Adds Biomarkers - technologies, markets and companies 9Reportlinker Adds Biomarkers - technologies, markets and companies 10Reportlinker Adds Biomarkers - technologies, markets and companies 11Reportlinker Adds Biomarkers - technologies, markets and companies 12Reportlinker Adds Biomarkers - technologies, markets and companies 13Reportlinker Adds Biomarkers - technologies, markets and companies 14Reportlinker Adds Biomarkers - technologies, markets and companies 15Reportlinker Adds Biomarkers - technologies, markets and companies 16Reportlinker Adds Biomarkers - technologies, markets and companies 17Reportlinker Adds Biomarkers - technologies, markets and companies 18Reportlinker Adds Biomarkers - technologies, markets and companies 19Reportlinker Adds Biomarkers - technologies, markets and companies 20Is organic farming good for wildlife? It depends on the alternative 2Is organic farming good for wildlife? It depends on the alternative 3Kaj Blennow's research into M. Alzheimer recognized by the 2010 ECNP Neuropsychopharmacology Award 2
(Date:12/22/2014)... (PRWEB) December 22, 2014 ... peer-reviewed publication of original research, reviews and editorials ... and clinical practice, today published a provocative article ... the development, progression and potential treatment of prostate ... endocrinology research and proposes the possibility that there ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... EVANSTON, Ill. , Dec. 19, 2014 ... to develop novel drugs for diseases of the central ... Ph.D., president and chief executive officer, will present at ... Dr. Riedel,s presentation will take place at 3:00 p.m. ... St. Francis in San Francisco, Calif. ...
(Date:12/19/2014)... Dec. 19, 2014 Decision Resources Group finds ... at a 12 percent compound annual growth rate through ... aging population and the increasing adoption of dental implants. ... will also spur demand for dental biomaterials because ... and periodontal treatments. Other key findings from ...
Breaking Biology Technology:Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3
... (Nasdaq: KOOL ) a leading supplier of ... administer,therapeutic doses of adult stem cells for treatment ... Osgood, the Company,s Chief Executive,Officer, and Mr. Matthew ... Global Life Sciences Conference to be held September ...
... ... -- Product revenues increase 26% to a record $47.6 million ... oximeter units shipped -- Net income of $10.6 million.$0.13 GAAP EPS ... MASI ), the inventor of Pulse CO-Oximetry and Read-Through Motion,and Low Perfusion pulse ...
... 19 ,Arpida Ltd (SWX: ARPN) presented a large ... drug iclaprim at the 47th annual Interscience,Conference on ... a major scientific conference where thousands of scientists ... discuss the latest,developments in the field of infectious ...
Cached Biology Technology:ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007 2ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007 3Masimo Reports Second Quarter 2007 Financial Results 2Masimo Reports Second Quarter 2007 Financial Results 3Masimo Reports Second Quarter 2007 Financial Results 4Masimo Reports Second Quarter 2007 Financial Results 5Masimo Reports Second Quarter 2007 Financial Results 6Masimo Reports Second Quarter 2007 Financial Results 7Masimo Reports Second Quarter 2007 Financial Results 8Masimo Reports Second Quarter 2007 Financial Results 9Masimo Reports Second Quarter 2007 Financial Results 10Masimo Reports Second Quarter 2007 Financial Results 11Masimo Reports Second Quarter 2007 Financial Results 12Masimo Reports Second Quarter 2007 Financial Results 13Masimo Reports Second Quarter 2007 Financial Results 14Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 2Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 3Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC 4
... Labeling Kit with CyScribe GFX Purification ... and purification of Cy3- and Cy5-labeled ... complete cDNA labeling and purification.Flexible and ... performing labeling reactions with either Cy3- ...
... CyScribe Post-Labeling Kit with CyScribe GFX ... generation and purification of Cy3- and ... for complete cDNA labeling and purification.Flexible ... for performing labeling reactions with either ...
Collected from sexually mature, mixed sex, mixed breed dogs. Serum from specific breeds available by request....
UV-NIR light source for USB2000, HR4000, HR2000+...
Biology Products: